PharmaBlock Sciences (Nanjing), Inc.
SZSE:300725.SZ
39.57 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 197.361 | 325.891 | 503.766 | 184.205 | 152.072 | 134.499 | 67.788 | 35.044 | 19.857 | 22.457 | 18.247 |
| Afschrijvingen & Amortisatie
| 116.086 | 88.03 | 54.995 | 24.474 | 21.118 | 16.9 | 12.321 | 8.55 | 4.237 | 3.5 | 3.115 |
| Uitgestelde Inkomstenbelasting
| 1.349 | -13.131 | -11.389 | -7.439 | -0.043 | -1.454 | -1.036 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 24.948 | 32.236 | 48.586 | 11.125 | 0 | 0 | 14.401 | 19.271 | 0 | 0 |
| Verandering in Werkkapitaal
| -213.796 | -216.026 | -155.121 | -16.444 | -63.957 | 6.125 | -33.526 | -34.92 | -14.065 | -15.13 | -3.642 |
| Vorderingen
| 37.374 | -31.422 | -133.74 | -100.9 | -68.586 | -7.652 | -10.756 | -11.678 | -17.561 | -2.132 | -2.7 |
| Voorraden
| -74.736 | -237.661 | -51.774 | -107.818 | -64.875 | -29.885 | -44.42 | -38.705 | -12.646 | -11.584 | -4.802 |
| Crediteuren
| -177.783 | 66.187 | 41.783 | 199.713 | 69.547 | 45.116 | 22.685 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 1.349 | -13.131 | -11.389 | -7.439 | -0.043 | 36.01 | 10.893 | 3.785 | -1.419 | -3.546 | 1.16 |
| Overige Niet-Contante Posten
| 145.84 | 36.897 | -186.457 | 38.123 | 6.73 | 2.637 | 8.057 | 14.084 | 17.495 | 1.083 | 0.596 |
| Kasstroom uit Operationele Activiteiten
| 246.84 | 246.609 | 238.03 | 271.506 | 127.045 | 160.161 | 54.64 | 22.758 | 27.524 | 11.91 | 18.316 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -315.775 | -557.907 | -505.759 | -75.18 | -173.522 | -48.437 | -49.063 | -38.263 | -9.704 | -9.479 | -6.233 |
| Netto Overnames
| -29.373 | -460.409 | -152.589 | 75.198 | -10.361 | -0.988 | 0.658 | -26.561 | -1.35 | -0.35 | 6.233 |
| Aankoop van Beleggingen
| -3,862.899 | -4,450.738 | -2,546.162 | -662.225 | -1,090.024 | -741.081 | -110 | 0 | -48.687 | -21.002 | -68.5 |
| Verkoop/verval van Beleggingen
| 3,236.399 | 4,414.727 | 2,289.962 | 592.803 | 972.988 | 751.409 | 0.032 | 2.229 | 56.066 | 20.245 | 68.029 |
| Overige Investeringsactiviteiten
| 27.865 | 460.69 | 0.203 | -75.18 | 0.251 | 0 | 4.5 | 3.5 | -0.076 | 0 | -6.233 |
| Kasstroom uit Investeringsactiviteiten
| -943.783 | -593.636 | -914.345 | -144.584 | -300.668 | -39.097 | -153.873 | -59.096 | -3.751 | -10.586 | -6.704 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| 128.911 | 1,256.102 | 169.435 | 60.014 | 0 | 24.924 | -3.501 | 0 | 0 | 0 | -2 |
| Uitgifte van Gewone Aandelen
| 0 | 1.018 | 0 | 955.628 | 54.222 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -20.033 | -1.018 | 0 | -955.628 | -54.222 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -19.966 | -19.966 | -15.362 | -21.718 | -22 | -15.669 | -0.061 | -0.508 | -10.01 | -6.853 | -0.449 |
| Overige Financieringsactiviteiten
| -23.541 | -474.757 | -8.852 | 954.37 | 73.097 | -28.7 | 186.046 | 50.197 | 31.903 | 0 | 0.16 |
| Kasstroom uit Financieringsactiviteiten
| 65.371 | 760.361 | 145.222 | 992.665 | 51.097 | -19.445 | 182.484 | 49.69 | 21.893 | -6.853 | -2.289 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 1.893 | 31.991 | -16.998 | -23.449 | 2.639 | 5.284 | -3.741 | 3.524 | 1.647 | -0.014 | -0.36 |
| Netto Kasstroomverandering
| -629.679 | 445.326 | -548.091 | 1,096.138 | -119.887 | 106.902 | 79.509 | 16.876 | 47.314 | -5.542 | 8.963 |
| Kaspositie aan het Einde van de Periode
| 508.272 | 1,137.95 | 692.625 | 1,240.715 | 144.578 | 264.465 | 157.562 | 78.053 | 61.177 | 13.864 | 19.406 |